BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 35950752)

  • 1. Regulated cell death in cancer: from pathogenesis to treatment.
    Gong L; Huang D; Shi Y; Liang Z; Bu H
    Chin Med J (Engl); 2023 Mar; 136(6):653-665. PubMed ID: 35950752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting regulated cell death (RCD) with small-molecule compounds in triple-negative breast cancer: a revisited perspective from molecular mechanisms to targeted therapies.
    Liao M; Qin R; Huang W; Zhu HP; Peng F; Han B; Liu B
    J Hematol Oncol; 2022 Apr; 15(1):44. PubMed ID: 35414025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research.
    Tong X; Tang R; Xiao M; Xu J; Wang W; Zhang B; Liu J; Yu X; Shi S
    J Hematol Oncol; 2022 Dec; 15(1):174. PubMed ID: 36482419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulated cell death (RCD) in cancer: key pathways and targeted therapies.
    Peng F; Liao M; Qin R; Zhu S; Peng C; Fu L; Chen Y; Han B
    Signal Transduct Target Ther; 2022 Aug; 7(1):286. PubMed ID: 35963853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulated cell death pathways and their roles in homeostasis, infection, inflammation, and tumorigenesis.
    Lee E; Song CH; Bae SJ; Ha KT; Karki R
    Exp Mol Med; 2023 Aug; 55(8):1632-1643. PubMed ID: 37612410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting regulated cell death (RCD) in hematological malignancies: Recent advances and therapeutic potential.
    Zhang Y; Zhou X
    Biomed Pharmacother; 2024 Jun; 175():116667. PubMed ID: 38703504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naturally derived indole alkaloids targeting regulated cell death (RCD) for cancer therapy: from molecular mechanisms to potential therapeutic targets.
    Qin R; You FM; Zhao Q; Xie X; Peng C; Zhan G; Han B
    J Hematol Oncol; 2022 Sep; 15(1):133. PubMed ID: 36104717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting regulated cell death with plant natural compounds for cancer therapy: A revisited review of apoptosis, autophagy-dependent cell death, and necroptosis.
    Yang Y; Chen Y; Wu JH; Ren Y; Liu B; Zhang Y; Yu H
    Phytother Res; 2023 Apr; 37(4):1488-1525. PubMed ID: 36717200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting regulated cell death (RCD) with small-molecule compounds in cancer therapy: A revisited review of apoptosis, autophagy-dependent cell death and necroptosis.
    Liu W; Jin W; Zhu S; Chen Y; Liu B
    Drug Discov Today; 2022 Feb; 27(2):612-625. PubMed ID: 34718209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modes of Regulated Cell Death in Cancer.
    Koren E; Fuchs Y
    Cancer Discov; 2021 Feb; 11(2):245-265. PubMed ID: 33462123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unraveling the Complexity of Regulated Cell Death in Esophageal Cancer: from Underlying Mechanisms to Targeted Therapeutics.
    Zhang H; Zhang J; Luan S; Liu Z; Li X; Liu B; Yuan Y
    Int J Biol Sci; 2023; 19(12):3831-3868. PubMed ID: 37564206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current evidence and therapeutic implication of PANoptosis in cancer.
    Ocansey DKW; Qian F; Cai P; Ocansey S; Amoah S; Qian Y; Mao F
    Theranostics; 2024; 14(2):640-661. PubMed ID: 38169587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innate immune inflammatory cell death: PANoptosis and PANoptosomes in host defense and disease.
    Chen W; Gullett JM; Tweedell RE; Kanneganti TD
    Eur J Immunol; 2023 Nov; 53(11):e2250235. PubMed ID: 36782083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulated Necrotic Cell Death in Alternative Tumor Therapeutic Strategies.
    Woo Y; Lee HJ; Jung YM; Jung YJ
    Cells; 2020 Dec; 9(12):. PubMed ID: 33348858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted regulated cell death with small molecule compounds in colorectal cancer: Current perspectives of targeted therapy and molecular mechanisms.
    Li R; Wu Y; Li Y; Shuai W; Wang A; Zhu Y; Hu X; Xia Y; Ouyang L; Wang G
    Eur J Med Chem; 2024 Feb; 265():116040. PubMed ID: 38142509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted therapy for non-small-cell lung cancer: New insights into regulated cell death combined with immunotherapy.
    Li S; Wang A; Wu Y; He S; Shuai W; Zhao M; Zhu Y; Hu X; Luo Y; Wang G
    Immunol Rev; 2024 Jan; 321(1):300-334. PubMed ID: 37688394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in tumor nanotechnology: theragnostic implications in tumors via targeting regulated cell death.
    Li J; Yi X; Liu L; Wang X; Ai J
    Apoptosis; 2023 Aug; 28(7-8):1198-1215. PubMed ID: 37184582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulated Cell Death in Pulpitis.
    Huang M; Zhan C; Yang X; Hou J
    J Endod; 2020 Oct; 46(10):1403-1413. PubMed ID: 32682790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging role of necroptosis, pyroptosis, and ferroptosis in breast cancer: New dawn for overcoming therapy resistance.
    Fu B; Lou Y; Wu P; Lu X; Xu C
    Neoplasia; 2024 Jun; 55():101017. PubMed ID: 38878618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heme Oxgenase-1, a Cardinal Modulator of Regulated Cell Death and Inflammation.
    Ryter SW
    Cells; 2021 Feb; 10(3):. PubMed ID: 33671004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.